We are live on ! Find out more
CEMI

Chembio diagnostics, Inc.
CEMI

Delisted

CEMI was delisted on the 27th of April, 2023.

Back to rankings

1 hedge funds and large institutions have $170 invested in Chembio diagnostics, Inc. in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% less funds holding

Funds holding: 30 → 1 (-29)

100% less capital invested

Capital invested by funds: $1.36M → $170 (-$1.36M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 29

Holders
1
Holders Change
-29
Holders Change %
-96.67%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
29
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$690K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$124K
3
BlackRock
BlackRock
New York
-$91.1K
4
PCM
PenderFund Capital Management
British Columbia, Canada
-$88K
5
Renaissance Technologies
Renaissance Technologies
New York
-$69K
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
26
BNP Paribas Financial Markets
France
– -$73 -165 Closed
TAM
27
Tucker Asset Management
Colorado
– -$22 -50 Closed
1
2

CEMI Hedge Fund Activity: Q2 2023 in Review

1 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q2 2023, worth a combined $170 — down 100% from $1.36M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of CEMI and 0 opened new positions — a net loss of 29 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $690K sold.

  • 1 institutional investor held Chembio diagnostics, Inc. (CEMI) as of Q2 2023, down from 30 in Q1 2023.
  • Funds reported $170 of Chembio diagnostics, Inc. stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Chembio diagnostics, Inc. positions in Q2 2023 and 29 closed out, a net change of -29 holders.
  • The largest Chembio diagnostics, Inc. seller in Q2 2023 was Vanguard Group, an estimated $690K sold.

Based on aggregated 13F filings for Q2 2023.